From Pilot to Impact: How Life Science Companies Can Overcome AI Adoption Barriers
The pharmaceutical and life sciences industry saw a rapid uptick in AI initiatives during 2024. A benchmark survey (Nov 2024) of 100 biotech, pharma, and MedTech executives revealed that 75% began implementing AI only in the past two years, reflecting how recent these efforts are1. Although still in the early stages, companies have…